Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma

Affiliations

• ¹ UKE, Department of Pediatric Hematology and Oncology, Hamburg.
• ² Hannover Medical School, Clinic for Pediatric Hematology and Oncology, Hannover.
• ³ St. Anna Children's Hospital, Medical University of Vienna, Department of Pediatric Hematology and Oncology, Vienna.
• ⁴ Charles University and University Hospital Motol, Department of Pediatric Hematology and Oncology, Prague, Czech Republic.
• ⁵ University of Gießen, Pediatric Hematology and Oncology, Gießen.
• ⁶ University Medical Center Göttingen, Division of Pediatric Hematology and Oncology, Göttingen.
• ⁷ Children's University Hospital Tübingen, Department of General Pediatrics and Pediatric Hematology/Oncology, Tübingen.
• ⁸ University-Hospital of Münster, Pediatric Hematology and Oncology, Münster.
• ⁹ Clinical Institute of Pathology, Medical University of Vienna, Vienna.
• ¹⁰ Universitätsklinikum Schleswig-Holstein, Campus Kiel, Institute of Pathology, Hematopathology Section and Lymph Node Registry, Kiel.
• ¹¹ UKE, Department of Pediatric Hematology and Oncology, Hamburg. w.woessmann@uke.de.